EXEL
Exelixis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$59.01
−0.20%0
Insider buys (3m)
1
Insider sells (3m)
-$526.5K
Net value (3m)
+12.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Beckerle Mary C · director | Sale | 9,812 | $54 |
| Jun 3, 2026 | WYSZOMIERSKI JACK L · director | Sale | 3,925 | $51 |
| Jun 3, 2026 | Eckhardt Sue Gail · director | Sale | 9,812 | $50 |
| May 29, 2026 | Beckerle Mary C · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | Oliver Bob · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | PAPADOPOULOS STELIOS · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | Smith Julie · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | JOHNSON DAVID EDWARD · director | A-Award | 19,133 | $50 |
| May 29, 2026 | Heyman Tomas J. · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | Freire Maria C · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | POSTE GEORGE · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | Eckhardt Sue Gail · director | A-Award | 8,367 | $0.00 |
| May 29, 2026 | WYSZOMIERSKI JACK L · director | A-Award | 8,367 | $0.00 |
| May 28, 2026 | Aftab Dana · officer: EVP, Research and Development | Sale | 43,451 | $50 |
| May 22, 2026 | Haley Patrick J. · officer: EVP, Commercial | Sale | 32,110 | $50 |
| May 19, 2026 | Senner Christopher J. · officer: EVP and CFO | F-InKind | 40,892 | $51 |
| May 19, 2026 | MORRISSEY MICHAEL · director, officer: President and CEO | F-InKind | 128,497 | $51 |
| May 19, 2026 | Aftab Dana · officer: EVP, Research and Development | F-InKind | 30,578 | $51 |
| May 19, 2026 | Hefti Brenda · officer: SVP and General Counsel | Sale | 6,625 | $50 |
| May 19, 2026 | Hefti Brenda · officer: SVP and General Counsel | F-InKind | 6,411 | $51 |
| May 19, 2026 | Haley Patrick J. · officer: EVP, Commercial | F-InKind | 33,265 | $51 |
| May 19, 2026 | Senner Christopher J. · officer: EVP and CFO | Sale | 34,901 | $50 |
| May 8, 2026 | Beckerle Mary C · director | Sale | 7,712 | $48 |
| May 8, 2026 | Freire Maria C · director | Sale | 20,634 | $46 |
| May 8, 2026 | Beckerle Mary C · director | M-Exempt | 3,856 | $23 |
| May 8, 2026 | POSTE GEORGE · director | Sale | 60,000 | $46 |
| May 8, 2026 | Freire Maria C · director | M-Exempt | 20,634 | $20 |
| Mar 2, 2026 | Haley Patrick J. · officer: EVP, Commercial | A-Award | 40,459 | $0.00 |
| Mar 2, 2026 | Hefti Brenda · officer: SVP and General Counsel | A-Award | 23,119 | $0.00 |
| Mar 2, 2026 | MORRISSEY MICHAEL · director, officer: President and CEO | A-Award | 160,437 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 239Increased 496Reduced 561Sold out 70
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 30,816,309 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 29,075,377 | Aug 7, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 13,726,993 | May 14, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 13,468,010 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 13,427,993 | Aug 13, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 13,111,010 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 13,095,741 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 12,085,273 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 12,043,122 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 11,258,984 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 11,023,943 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 10,950,997 | Aug 13, 2026 |
| STATE STREET CORP | Reduced | 10,298,439 | May 15, 2026 |
| STATE STREET CORP | Reduced | 9,970,071 | Aug 7, 2026 |
| FULLER & THALER ASSET MANAGEMENT, INC. | Increased | 8,929,389 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 12, 2026